StockNews com Begins Coverage on AcelRx Pharmaceuticals (NASDAQ:ACRX) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
AcelRx Pharmaceuticals (NASDAQ:ACRX – Get Free Report) will be issuing its quarterly earnings data after the market closes on Wednesday, November 8th. Analysts expect the company to announce earnings of ($0.29) per share for the quarter. Parties interested in listening to the company’s conference call can do so using this link. AcelRx Pharmaceuticals (NASDAQ:ACRX – […]
Equities researchers at StockNews.com initiated coverage on shares of AcelRx Pharmaceuticals (NASDAQ:ACRX – Get Free Report) in a research report issued on Thursday. The brokerage set a “sell” rating on the specialty pharmaceutical company’s stock. ACRX has been the topic of several other research reports. Alliance Global Partners assumed coverage on AcelRx Pharmaceuticals in a […]
AcelRx Pharmaceuticals (NASDAQ:ACRX – Free Report) had its price target trimmed by HC Wainwright from $8.00 to $5.00 in a research note issued to investors on Monday, MarketBeat reports. The brokerage currently has a buy rating on the specialty pharmaceutical company’s stock. HC Wainwright also issued estimates for AcelRx Pharmaceuticals’ FY2024 earnings at ($0.75) EPS, […]
AcelRx Pharmaceuticals (NASDAQ:ACRX – Free Report) had its target price trimmed by HC Wainwright from $8.00 to $5.00 in a research report sent to investors on Monday morning, Marketbeat reports. The firm currently has a buy rating on the specialty pharmaceutical company’s stock. HC Wainwright also issued estimates for AcelRx Pharmaceuticals’ FY2024 earnings at ($0.75) […]